Concepedia

Jian-cheng Ding

JD

Statistics

Publications

4

Citations

70

H-Index

4

Active since

2023

Affiliations

Xiamen University(Current)

Guangzhou Regenerative Medicine and Health Guangdong Laboratory

Jian-cheng Ding is an author at Xiamen University specializing in life sciences, oncology, and innate immunity pathways.

Publications per year

2023–2024

4

Publications

4

MAVI1, an endoplasmic reticulum–localized microprotein, suppresses antiviral innate immune response by targeting MAVS on mitochondrion

Tao-tao Shi, Ying Huang, Ying Li et al. · Science Advances · 2023 · 24 citations · Full text

Life Sciences, Immunology, Microbiology +17

Targeting the PHF8/YY1 axis suppresses cancer cell growth through modulation of ROS

Xiaonan Wu, Jia-yuan Li, Qi He et al. · Proceedings of the National Academy of Sciences · 2024 · 20 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

A deregulated m <sup>6</sup> A writer complex axis driven by BRD4 confers an epitranscriptomic vulnerability in combined DNA repair–targeted therapy

Lu Xiao, Lichao Peng, Jian-cheng Ding et al. · Proceedings of the National Academy of Sciences · 2023 · 13 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

A CARM1 Inhibitor Potently Suppresses Breast Cancer Both In Vitro and In Vivo

Bing‐ling Peng, Ting Ran, Xue Chen et al. · Journal of Medicinal Chemistry · 2024 · 13 citations · Full text

Medicine, Oncology, Pharmacology +17

1–4 of 4